Kochav S, Coromilas E, Nalbandian A, Ranard L, Gupta A, Chung M
Circ Arrhythm Electrophysiol. 2020; 13(6):e008719.
PMID: 32434385
PMC: 7299099.
DOI: 10.1161/CIRCEP.120.008719.
Shenfield G, Evans M, Paterson J
Br J Clin Pharmacol. 2012; 1(4):295-300.
PMID: 22454882
PMC: 1402431.
DOI: 10.1111/j.1365-2125.1974.tb00256.x.
Shenfield G, Evans M, Paterson J
Br J Clin Pharmacol. 2012; 3(4):583-9.
PMID: 22216498
PMC: 1428916.
DOI: 10.1111/j.1365-2125.1976.tb04879.x.
Cazzola M, Matera M, Donner C
Drugs. 2005; 65(12):1595-610.
PMID: 16060696
DOI: 10.2165/00003495-200565120-00001.
Walters E, Walters J
Cochrane Database Syst Rev. 2000; (4):CD001285.
PMID: 11034709
PMC: 8407398.
DOI: 10.1002/14651858.CD001285.
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.
Sears M, Taylor D
Drug Saf. 1994; 11(4):259-83.
PMID: 7848546
DOI: 10.2165/00002018-199411040-00005.
Treatment of severe anaphylactic reactions to insect stings.
ACKROYD J
J R Soc Med. 1981; 74(8):567-9.
PMID: 7288789
PMC: 1438926.
DOI: 10.1177/014107688107400801.
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.
Harvey J, Tattersfield A
Thorax. 1982; 37(4):280-7.
PMID: 7112457
PMC: 459298.
DOI: 10.1136/thx.37.4.280.
Progress in asthma.
PALMER K
Postgrad Med J. 1969; 45(523):336-41.
PMID: 5790933
PMC: 2466538.
DOI: 10.1136/pgmj.45.523.336.
The cardio-toxicity of isoprenaline during hypoxia.
Collins J, McDevitt D, Shanks R, Swanton J
Br J Pharmacol. 1969; 36(1):35-45.
PMID: 5768127
PMC: 1703542.
DOI: 10.1111/j.1476-5381.1969.tb08301.x.
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.
Warrell D, Robertson D, Howes J, Conolly M, Paterson J, Beilin L
Br Med J. 1970; 1(5688):65-70.
PMID: 5411446
PMC: 1699164.
Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs.
Daly M, Farmer J, Levy G
Br J Pharmacol. 1971; 43(3):624-38.
PMID: 5290549
PMC: 1665801.
DOI: 10.1111/j.1476-5381.1971.tb07192.x.
Hemodynamic effects of isoproterenol on the pulmonary and systemic circulations in dogs.
Turnheim K, Stuhlinger W, KRAUPP O
Pflugers Arch. 1971; 322(4):310-22.
PMID: 5100178
DOI: 10.1007/BF00587749.
Deaths from asthma in young people.
Br Med J. 1972; 1(5798):459.
PMID: 5008049
PMC: 1787458.
Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma.
SIMPSON W, GRANT I
Br Med J. 1969; 2(5652):287-9.
PMID: 4888877
PMC: 1983176.
DOI: 10.1136/bmj.2.5652.287.
Recognition of unwanted drug effects.
DOLL R
Br Med J. 1969; 2(5649):69-76.
PMID: 4887042
PMC: 1982879.
DOI: 10.1136/bmj.2.5649.69.
Further observations on the cardiotoxicity of isoprenaline during hypoxia.
McDevitt D, Shanks R, Swanton J
Br J Pharmacol. 1974; 50(3):335-44.
PMID: 4852115
PMC: 1776702.
DOI: 10.1111/j.1476-5381.1974.tb09608.x.
Asthma deaths: a question answered.
Br Med J. 1972; 4(5838):443-4.
PMID: 4653869
PMC: 1786725.
Investigation into isoprenaline resistance in patients with obstructive lung disease.
Lichterfeld A, Lollgen H
Eur J Clin Pharmacol. 1974; 7(5):347-51.
PMID: 4609138
DOI: 10.1007/BF00558204.
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).
Conolly M, Davies D, Dollery C, George C
Br J Pharmacol. 1971; 43(2):389-402.
PMID: 4400573
PMC: 1665912.
